Vol 10, No 6 (December 31, 2021): Chinese Clinical Oncology

Editorial on Inflammatory Breast Cancer¹

“Why and What” for the optimal management of inflammatory breast cancer

Naoto T. Ueno, Angela Alexander

PDF Pages: 54 Full Text (1616) COI Form Open Access

Review Article on Inflammatory Breast Cancer¹

What is the best systemic treatment for newly diagnosed inflammatory breast cancer?—a narrative review

Sudpreeda Chainitikun, Siyamol Mingmalairak, Napa Parinyanitikul

PDF Pages: 55 Full Text (2599) Reporting Checklist COI Form Open Access

Baseline FDG PET-CT imaging is necessary for newly diagnosed inflammatory breast cancer patients: a narrative review

Miral M. Patel, Huong T. Le-Petross

PDF Pages: 56 Full Text (2433) Reporting Checklist COI Form Open Access

Contemporary surgical management of inflammatory breast cancer: a narrative review

Taiwo Adesoye, Shelby Irwin, Susie X. Sun, Anthony Lucci, Mediget Teshome

PDF Pages: 57 Full Text (3579) Reporting Checklist COI Form Open Access

Why diagnosing inflammatory breast cancer is hard and how to overcome the challenges: a narrative review

Huong T. Le-Petross, Wintana Balema, Wendy A. Woodward

PDF Pages: 58 Full Text (15634) Reporting Checklist COI Form Open Access

What is the best treatment recommendation for HER2+ IBC with residual disease?—a narrative review

Danielle B. Zakon, Vicente Valero

PDF Pages: 59 Full Text (2497) COI Form Open Access

How should radiation be done for inflammatory breast cancer patients?—a narrative review of modern literature

Kelsey L. Corrigan, Wendy A. Woodward, Michael C. Stauder

PDF Pages: 60 Full Text (4325) Reporting Checklist COI Form Open Access

Disclosure:

1. The series “Inflammatory Breast Cancer” was commissioned by the Editorial office, Chinese Clinical Oncology without any sponsorship or funding. Professor Naoto T. Ueno served as the unpaid Guest Editor for the series.